Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 39Colonic Neoplasms 14Colorectal Neoplasms 13Neoplasms 12Rectal Neoplasms 11Prostatic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Obesity 8Motor Activity 8Lung Neoplasms 8Endometrial Neoplasms 8Tobacco Use Disorder 6Small Cell Lung Carcinoma 6Overweight 6Depression 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Urinary Bladder Neoplasms 4Sexuality 4Sexual Dysfunction, Physiological 4Leukemia 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Intraductal, Noninfiltrating 4Body Weight Changes 4

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castration-Resistant Prostate Cancer (CRPC) × Counseling × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡